John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$976M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$219M |
| 3 |
Humana
HUM
|
+$215M |
| 4 |
Pinterest
PINS
|
+$214M |
| 5 |
Snowflake
SNOW
|
+$204M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$301M |
| 2 |
Tesla
TSLA
|
+$254M |
| 3 |
Nike
NKE
|
+$248M |
| 4 |
Procter & Gamble
PG
|
+$233M |
| 5 |
Pfizer
PFE
|
+$232M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.09% |
| 2 | Financials | 10.23% |
| 3 | Consumer Discretionary | 10.17% |
| 4 | Healthcare | 10.17% |
| 5 | Industrials | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ORGN
2801
DELISTED
Origin Materials
ORGN
| $191K | ﹤0.01% |
+7,612
| New | +$218K |
|
2802
Nuvectis Pharma
NVCT
$799M
| $190K | ﹤0.01% |
+22,771
| New | +$203K |
|
|
VIP
2803
Vulcan Infrastructure and Power
VIP
$33.7M
| $188K | ﹤0.01% |
+28,058
| New | +$142K |
|
|
SLI
2804
Standard Lithium
SLI
$632M
| $188K | ﹤0.01% |
93,137
+75,759
| +436% | +$189K |
|
|
WKME
2805
DELISTED
WalkMe Ltd. Ordinary Shares
WKME
| $188K | ﹤0.01% |
+17,594
| New | +$166K |
|
2806
Voyager Therapeutics
VYGR
$214M
| $187K | ﹤0.01% |
22,100
-11,500
| -34% | -$83.4K |
|
|
RPTX
2807
DELISTED
Repare Therapeutics
RPTX
| $186K | ﹤0.01% |
+25,476
| New | +$143K |
|
2808
Tilly's
TLYS
$114M
| $186K | ﹤0.01% |
+24,640
| New | +$198K |
|
2809
Verastem
VSTM
$644M
| $184K | ﹤0.01% |
22,612
-22,583
| -50% | -$162K |
|
2810
Lifeway Foods
LWAY
$397M
| $182K | ﹤0.01% |
+13,556
| New | +$171K |
|
|
TPIC
2811
DELISTED
TPI Composites
TPIC
| $181K | ﹤0.01% |
43,750
-82,940
| -65% | -$216K |
|
2812
Perimeter Solutions
PRM
$5.16B
| $181K | ﹤0.01% |
39,243
-30,308
| -44% | -$116K |
|
|
KLRS
2813
Kalaris Therapeutics
KLRS
$99M
| $180K | ﹤0.01% |
11,502
+10,005
| +668% | +$395K |
|
2814
Pixelworks
PXLW
$42.8M
| $178K | ﹤0.01% |
11,313
-2,943
| -21% | -$42.7K |
|
2815
Ceragon Networks
CRNT
$188M
| $177K | ﹤0.01% |
82,074
+24,500
| +43% | +$45K |
|
|
QIPT
2816
DELISTED
Quipt Home Medical
QIPT
| $176K | ﹤0.01% |
34,600
-8,245
| -19% | -$39.5K |
|
2817
Nexa Resources
NEXA
$2.06B
| $176K | ﹤0.01% |
+24,658
| New | +$145K |
|
2818
Townsquare Media
TSQ
$106M
| $176K | ﹤0.01% |
+16,641
| New | +$157K |
|
2819
Tejon Ranch
TRC
$437M
| $175K | ﹤0.01% |
10,203
-2,544
| -20% | -$41.3K |
|
|
CTLP
2820
DELISTED
Cantaloupe
CTLP
| $175K | ﹤0.01% |
23,657
+12,157
| +106% | +$84K |
|
2821
OP Bancorp
OPBK
$226M
| $175K | ﹤0.01% |
16,005
| – | – |
|
|
TRVG
2822
trivago
TRVG
$402M
| $175K | ﹤0.01% |
71,645
+39,420
| +122% | +$154K |
|
2823
Immunic
IMUX
$225M
| $175K | ﹤0.01% |
11,649
-23,598
| -67% | -$289K |
|
|
DZSI
2824
DELISTED
DZS Inc. Common Stock
DZSI
| $173K | ﹤0.01% |
87,706
-19,834
| -18% | -$31.1K |
|
|
KRON
2825
DELISTED
Kronos Bio
KRON
| $173K | ﹤0.01% |
138,213
-61,925
| -31% | -$68.5K |
|
Similar funds
John Overdeck's Q4 2023 Portfolio in Review
As of Q4 2023, John Overdeck held 3,484 positions worth $43.5B, up 17% from $37.2B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
John Overdeck's Q4 2023 filing shows 550 new, 1,237 increased, 1,116 reduced and 366 closed positions. Its largest new stake was Becton Dickinson: 732,254 shares worth $179M. The largest sale was Palantir, an estimated $301M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
- John Overdeck's largest Q4 2023 buy was Becton Dickinson: 732,254 shares worth $179M.
- John Overdeck added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $976M increase.
- John Overdeck's biggest Q4 2023 reduction was Palantir, cutting an estimated $301M.
- John Overdeck fully exited Tesla in Q4 2023, selling an estimated $254M.
- John Overdeck's ten largest holdings make up 9.3% of its $43.5B portfolio in Q4 2023.
- John Overdeck opened 550 new positions and closed 366 in Q4 2023.
- John Overdeck's portfolio value rose 17% quarter-over-quarter to $43.5B.
Based on Two Sigma Investments's 13F filing for Q4 2023, filed 14 Feb 2024.